| Literature DB >> 33877483 |
Kerstin Piayda1, Lisa Dannenberg1, Saif Zako1, Oliver Maier1, Georg Bosbach1, Amin Polzin1, Shazia Afzal1, Christian Jung1, Ralf Westenfeld1, Malte Kelm1,2, Tobias Zeus1, Verena Veulemans3.
Abstract
We investigated aortic valve calcification (AVC) distribution and predictors for leaflet calcification patterns in patients with severe tricuspid aortic valve stenosis undergoing transcatheter aortic valve replacement (TAVR). Patients undergoing routine multi-sliced computed tomography (MSCT) for procedural planning were enrolled. MSCT data were transferred to a dedicated workstation for evaluation (3mensio Structural Heart™, Pie Medical Imaging BV, Maastricht, The Netherlands) and analyzed. Participants were separated into asymmetrical (AC) and symmetrical (SC) leaflet calcification and potential predictors for calcification distribution were identified with univariate and multivariate regression analysis. 567 Participants with severe tricuspid AS were divided into asymmetrical (AC, n = 443; 78.1%) and symmetrical (SC, n = 124; 21.9%) AVC. In AC, the non-coronary cusp was the most calcified cusp (n = 238; 57.7%). SC is more common in females (AC/SC: 49.2% vs. 67.7%; p < 0.0001). AVC was more severe in patients with AC, who also have larger aortic root dimensions. Multivariate analysis depicted, inter alia, left ventricular outflow tract (LVOT) calcification < 25 Agatston units (OR 1.81 [1.09-3.00], p = 0.021), a mean pressure gradient < 36 mmHg (OR 1.77 [1.03-3.05], p = 0.039), and an annulo-apical angle > 67° (OR 1.68 [1.00-2.80], p = 0.049) as predictors for SC, although with only moderate predictive value. Data from this retrospective analysis indicate that SC occurs more frequently in females. The cumulative leaflet calcification burden is higher in patients with AC, who also present with larger aortic root dimensions. The predictive value for prominent calcification of different aortic valve cusps in AC patients was only low to moderate.Trial registration number: NCT01805739.Entities:
Keywords: Aortic valve calcification distribution; Leaflet calcification; Multi‐sliced computed tomography analysis; Severe aortic stenosis; TAVR
Mesh:
Year: 2021 PMID: 33877483 PMCID: PMC8390394 DOI: 10.1007/s10554-021-02248-6
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
Patients’ clinical and functional characteristics
| Overall (n = 567; 100%) | Asymmetrical (AC) (n = 443; 78.1%) | Symmetrical (SC) (n = 124; 21.9%) | p-value | |
|---|---|---|---|---|
| Calcium distribution | ||||
| Non-coronary cusp | 238 (42.0) | 238 (42.0) |
| |
| Right coronary cusp | 72 (12.7) | 72 (12.7) |
|
|
| Left coronary cusp | 58 (10.2) | 58 (10.2) |
|
|
| Non-coronary cusp = Right coronary cusp | 36 (6.3) | 36 (6.3) |
|
|
| Non-coronary cusp = Left coronary cusp | 27 (4.8) | 27 (4.8) |
|
|
| Left coronary cusp = Right coronary cusp | 12 (2.1) | 12 (2.1) |
|
|
| Clinical data | ||||
| Age (years) | 81.8 ± 5.7 | 81.8 ± 5.6 | 81.7 ± 5.8 | 0.804 |
| Female | 302 (53.3) | 218 (49.2) | 84 (67.8) |
|
| Body mass index | 26.7 ± 4.7 | 26.6 ± 4.5 | 27.1 ± 5.3 | 0.262 |
| Malignancy | 14 (2.5) | 10 (2.3) | 4 (3.2) | 0.519 |
| Coronary artery disease | 408 (72.2) | 323 (73.2) | 85 (68.5) | 0.740 |
| Previous percutaneous coronary intervention | 225 (39.7) | 183 (41.3) | 42 (33.9) | 0.063 |
| Previous coronary artery bypass grafting | 64 (11.3) | 53 (12.0) | 11 (8.9) | 0.422 |
| Arterial hypertension | 517 (91.2) | 404 (91.1) | 113 (91.2) | 1.000 |
| Pulmonary hypertension | 350 (61.8) | 268 (60.6) | 82 (66.1) | 0.296 |
| Diabetes mellitus | 173 (30.5) | 128 (28.9) | 45 (36.3) | 0.158 |
| Insulin-dependent | 72 (12.7) | 50 (11.3) | 22 (17.7) | 0.067 |
| Immunosuppression | 22 (3.9) | 12 (2.7) | 10 (8.1) |
|
| Smoker | 95 (16.8) | 79 (17.8) | 16 (12.9) | 0.222 |
| Previous pacemaker | 77 (13.6) | 57 (12.9) | 20 (16.1) | 0.374 |
| Chronic obstructive pulmonary disease | 182 (32.1) | 126 (28.4) | 56 (45.2) |
|
| Atrial fibrillation | 228 (40.2) | 180 (40.6) | 48 (38.7) | 0.756 |
| Porcelain aorta | 51 (9.0) | 40 (9.0) | 11 (8.9) | 1.000 |
| Medication | ||||
| Oral anticoagulation | 237 (41.9) | 182 (41.2) | 55 (44.4) | 0.538 |
| Statin | 353 (62.4) | 280 (63.3) | 73 (58.9) | 0.402 |
| Rheology | ||||
| Creatinine (mg/dl) | 1.3 ± 0.9 | 1.3 ± 0.8 | 1.3 ± 1.1 | 0.424 |
| Glomerular filtration rate (ml/min) | 55.5 ± 20.0 | 56.0 ± 20.2 | 53.8 ± 19.6 | 0.274 |
| Hemoglobin (g/dl) | 12.3 ± 5.0 | 12.4 ± 5.6 | 12.1 ± 1.6 | 0.532 |
| Functional data | ||||
| Log EuroSCORE (%) | 25.2 ± 14.5 | 25.3 ± 14.9 | 24.8 ± 13.2 | 0.735 |
| Cardiac index (l/min/m2) | 2.3 ± 0.6 | 2.4 ± 0.6 | 2.3 ± 0.5 | 0.160 |
| Severely reduced LVF (< 35%) | 44 (7.8) | 33 (7.4) | 11 (8.9) | 0.789 |
| Aortic regurgitation ≥ II° | 99 (17.5) | 76 (17.8) | 23 (18.7) | 0.791 |
| Mitral stenosis ≥ II° | 38 (6.8) | 29 (6.6) | 28 (22.6) | 0.839 |
| Mitral regurgitation ≥ II° | 126 (22.2) | 93 (20.9) | 33 (26.6) | 0.222 |
| Tricuspid regurgitation ≥ II° | 100 (17.7) | 76 (17.1) | 24 (19.3) | 0.595 |
| Systolic pulmonary artery pressure (mmHg) | 43.1 ± 15.0 | 42.6 ± 14.9 | 44.8 ± 15.0 | 0.238 |
| PCWP (mmHg) | 17.6 ± 9.3 | 16.7 ± 8.1 | 20.5 ± 12.1 |
|
| PVR (dynes/cm5) | 225.5 ± 205.4 | 225.2 ± 217.2 | 226.5 ± 159.4 | 0.964 |
| SVR (dynes/cm5) | 1821 ± 670.4 | 1798 ± 687.7 | 1894 ± 609.6 | 0.281 |
| LVEDP (mmHg) | 21.6 ± 8.8 | 21.6 ± 8.3 | 21.6 ± 10.3 | 0.988 |
| Aortic valve area (cm2) | 0.8 ± 0.2 | 0.7 ± 0.2 | 0.8 ± 0.2 |
|
| Maximum pressure gradient (mmHg) | 60.5 ± 23.4 | 62.2 ± 23.2 | 54.2 ± 23.2 |
|
| Mean pressure gradient (mmHg) | 37.3 ± 15.3 | 38.3 ± 15.2 | 33.9 ± 15.6 |
|
| Multi-sliced computed tomography data | ||||
| Aortic valve calcification (AU) | 1976 [952–2658] | 2208 [1188–2906] | 1143 [495–1641] |
|
| Non-coronary cusp (AU) | 829 [324–1175] | 964 [474–1283] | 352 [139–466] |
|
| Left coronary cusp (AU) | 543 [216–745] | 599 [260–824] | 344 [133–491] |
|
| Right coronary cusp (AU) | 583 [227–763] | 655 [270–843] | 326 [115–432] |
|
| Left ventricular outflow tract (AU) | 188 [0–186] | 182 [0–188] | 209 [1 | 0.481 |
| Annulus area (cm2) | 4.7 ± 1.0 | 4.8 ± 1.0 | 4.5 ± 1.0 |
|
| Perimeter (mm) | 77.0 ± 8.4 | 77.6 ± 8.6 | 74.8 ± 7.5 |
|
| Annulus ellipticity | 1.2 ± 0.1 | 1.2 ± 0.1 | 1.2 ± 0.1 | 0.121 |
| Left ventricular outflow tract mean (mm) | 23.6 ± 2.8 | 23.8 ± 2.7 | 22.9 ± 2.8 |
|
| Left ventricular outflow tract ellipticity | 1.4 ± 0.2 | 1.4 ± 0.2 | 1.4 ± 0.2 |
|
| Sinotubular junction mean (mm) | 29.1 ± 3.3 | 29.3 ± 6.4 | 28.3 ± 3.2 | 0.105 |
| AOA mean (mm) | 33.4 ± 3.5 | 33.4 ± 3.5 | 33.4 ± 3.6 | 0.886 |
| Sinus of Valsalva diameter (mm) | 35.1 ± 9.3 | 35.3 ± 9.3 | 34.2 ± 9.3 | 0.259 |
| Sinus of Valsalva radius NCC (mm) | 17.9 ± 5.0 | 18.1 ± 5.0 | 18.4 ± 4.9 | 0.167 |
| Sinus of Valsalva radius LCC (mm) | 17.8 ± 4.9 | 17.9 ± 4.9 | 17.4 ± 4.7 | 0.346 |
| Sinus of Valsalva radius RCC (mm) | 17.1 ± 4.7 | 17.2 ± 4.7 | 16.6 ± 4.7 | 0.186 |
| Right coronary artery distance (mm) | 15.0 ± 3.1 | 15.1 ± 3.1 | 14.7 ± 3.1 | 0.197 |
| Left coronary artery distance (mm) | 12.3 ± 2.7 | 12.4 ± 2.7 | 11.8 ± 2.6 |
|
| Right coronary cusp length (mm) | 10.5 ± 2.1 | 10.6 ± 2.1 | 10.2 ± 1.8 |
|
| Left coronary cusp length (mm) | 11.0 ± 2.0 | 11.1 ± 2.0 | 10.5 ± 2.0 |
|
| Ratio Right coronary artery/Right coronary cusp | 1.5 ± 0.4 | 1.5 ± 0.4 | 1.5 ± 0.3 | 0.784 |
| Ratio Left coronary artery/Left coronary cusp | 1.2 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.2 | 0.812 |
| Aortic root angulation (°) | 48.9 ± 10.7 | 49.3 ± 10.3 | 47.7 ± 11.8 | 0.191 |
| Annulo-apical angulation (°) | 67.5 ± 13.7 | 67.1 ± 13.2 | 69.1 ± 15.3 | 0.208 |
*Significant level p < 0.05 (bold, italics)
Values are mean ± SD, mean ± 25th and 75th percentile or n (%)
AU Agatston units, BMI body mass index, CABG coronary artery bypass graft, CAD coronary artery disease, CI cardiac index, COPD chronic obstructive pulmonary disease, CVD cerebrovascular disease, dPmean/max mean/max. transvalvular gradient, LCC Left coronary cusp, LVEDP Left ventricular enddiastolic pressure, LVEF Left ventricular ejection fraction, LAO left anterior oblique, LVOT Left ventricular outflow tract, NCC Non-coronary cusp, PCI percutaneous coronary intervention, PHT pulmonary hypertension, RCC Right coronary cusp, SOV Sinus of Valsalva, STJ Sinotubular junction
Discrimination performance (ROC and AUC statistics)
| Calcification site | Parameters | AUC | p-value | Lower 95% CI | Upper 95% CI |
|---|---|---|---|---|---|
| Symmetrical | Chronic obstructive pulmonary disease | 0.58 |
| 0.51 | 0.65 |
| Left ventricular outflow tract < 25 AU | 0.60 |
| 0.53 | 0.66 | |
| Mean pressure gradient < 36 mmHg | 0.59 |
| 0.52 | 0.66 | |
| Annulo-apical angulation > 67° | 0.56 | 0.089 | 0.49 | 0.63 | |
| Combined AUC | 0.68 |
| 0.62 | 0.74 | |
| Non-coronary cusp | Previous coronary artery bypass grafting | 0.53 | 0.233 | 0.48 | 0.58 |
| No porcelain aorta | 0.53 | 0.342 | 0.48 | 0.58 | |
| Combined AUC | 0.55 |
| 0.50 | 0.60 | |
| Left coronary cusp | – | – | – | – | – |
| RCC | No permanent pacemaker | 0.56 | 0.157 | 0.48 | 0.63 |
| Annulus ellipticity < 1.22 | 0.60 |
| 0.52 | 0.68 | |
| Ratio right coronary artery/right coronary cusp > 1.43 | 0.58 |
| 0.51 | 0.66 | |
| Annulo-apical angulation < 67° | 0.57 | 0.099 | 0.49 | 0.64 | |
| Combined AUC | 0.68 |
| 0.61 | 0.75 |
*Significant level p < 0.05 (bold, italics)
Values are mean ± SD, mean ± 25th and 75th percentile or n (%)
AU Agatston units, CABG coronary artery bypass graft, COPD chronic obstructive pulmonary disease, LCC Left coronary cusp, LVOT Left ventricular outflow tract, NCC Non-coronary cusp, PM Pacemaker, RCA Right coronary artery, RCC Right coronary cusp, SOV Sinus of Valsalva, STJ Sinotubular junction
Fig. 1Calcification distribution and independent predictors. The amount of calcium of the aortic valve and surrounding structures were assessed and re-calculated in Agatston Units (AU) for overall- and separated leaflet calcium burden. Symmetrical and asymmetrical leaflet calcification with the dominant calcified cusp (non coronary cusp-magenta; left coronary cusp-blue; right coronary cusp-yellow) are displayed with independent predictors—identified by multivariate analysis. CABG coronary artery bypass grafting, COPD chronic obstructive pulmonary disease, dPmean mean pressure gradient, PPM permanent pacemaker, Ratio RCA/RCCb ratio of the right coronary artery to the base of the right coronary cusp